Evidence map›Paper›PMID 38776129›Full record

ArticleMolecular biology of the cell2024

Sur7 mediates a novel pathway for PI

Carla E Lanze, James B Konopka

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Regulation of yeast polarized exocytosis by phosphoinositide lipids.Cellular and molecular life sciences : CMLS · 2024
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Carla E LanzeDepartment of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794-5222.
James B KonopkaDepartment of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794-5222.

Funding

Regulation of Morphogenesis in C. albicansR01AI047837 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI James B Konopka · 2001 to 2026
$8.8M
MOLECULAR AND CELL BIOLOGY OF INFECTIOUS DISEASEST32AI007539 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI KONOPKA, JAMES B · 1998 to 2023
$3.6M
C. albicans invasive growthR01AI177553 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI James B Konopka · 2024 to 2026
$2.0M
NIAID NIH HHS R01 AI047837NIAID NIH HHS R01 AI177553NIAID NIH HHS T32 AI007539
6 · The paper itself

Abstract

The human fungal pathogen

Indexed as

Candida albicansCell WallFungal ProteinsMorphogenesisCell MembraneGene Expression Regulation, FungalHyphaePhosphatidylinositol 4,5-DiphosphatePhosphoric Monoester HydrolasesStress, PhysiologicalVirulenceFungal ProteinsPhosphatidylinositol 4,5-DiphosphatePhosphoric Monoester Hydrolases

Identifiers

PMID38776129
PMCPMC11244165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.